Back to results
US 7,183,270 B2Granted
Cyclic derivatives as modulators of chemokine receptor activity
AssigneeBristol-Myers Squibb Company
InventorsRobert J. Cherney, Percy H. Carter, John V. Duncia, Daniel S. Gardner, Joseph B. Santella
Life of this patent
Estimating the term…
Abstract
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.
Claims19
A compound of formula (I):
- or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein:
- ring B is a cyclohexyl group, ring B being substituted with 0–2 R5;
- X is selected from O or S;
- Z is —NR9—;
- wherein neither Z nor R13 are connected to a carbon atom labeled (b);
- bond (a) is a single bond;
- E is selected from —S(O)pCHRe—, —CHReNRe—, —C(O)—NRe—, —NReC(O)NRe—, —SO2—NRe—, and —NReSO2NRe—;
- Re is independently selected from H and C1-3 alkyl;
- R1 is selected from a C6-10 aryl group substituted with 0–5 R6;
- R2 is selected from a 5–10 membered heteroaryl system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R7;
- R5, at each occurrence, is independently selected from H, ═O, C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CRR)rOH, (CRR)rSH, (CRR)rOR5d, ′(CRR)rSR5d, (CRR)rNR5aR5a, (CRR)rN(→O)R5aR5a, N3, (CRR)rC(O)OH, (CRR)rC(O)R5b, (CRR)rC(O)NR5aR5a, (CRR)rNR5aC(O)R5b, (CRR)rOC(O)NR5aR5a, (CRR)rNR5aC(O)OR5d, (CRR)rNR5aC(O)NR5aR5a, (CRR)rNR5aC(O)H, (CRR)rC(O)OR5d, (CRR)rOC(O)R5b, (CRR)rS(O)pR5b, (CRR)rS(O)2NR5aR5a, (CRR)rNR5aS(O)2R5b, (CRR)rNR5aS(O)2NR5aR5a, C1-6 haloalkyl, a (CRR)r—C3-10 carbocyclic residue substituted with 0–3 R5c, and a (CRR)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–2 R5c;
- R5a, at each occurrence, is independently selected from H, methyl substituted with 0–1 R5g, C2-6 alkyl substituted with 0–2 R5e, C3-8 alkenyl substituted with 0–2 R5e, C3-8 alkynyl substituted with 0–2 R5e, a (CH2)r—C3-10 carbocyclic residue substituted with 0–5 R5e, and a (CH2)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R5e;
- R5b, at each occurrence, is selected from C1-6 alkyl substituted with 0–3 R5e, C3-8 alkenyl substituted with 0–2 R5e, C3-8 alkynyl substituted with 0–2 R5e, a (CH2)rC3-6 carbocyclic residue substituted with 0–2 R5e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R5e;
- R5c, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, (CF2)rCF3, NO2, CN, (CH2)rNR5fR5f, (CH2)rOH, (CH2)rOC1-4 alkyl, (CH2)rSC1-4 alkyl, (CH2)rC(O)OH, (CH2)rC(O)R5b, (CH2)rC(O)NR5fR5f, (CH2)rOC(O)NR5fR5f, (CH2)rNR5fC(O)R5b, (CH2)rC(O)OC1-4 alkyl, (CH2)rNR5fC(O)OC1-4 alkyl, (CH2)rOC(O)R5b, (CH2)rC(═NR5f)NR5fR5f, (CH2)rS(O)pR5b, (CH2)rNHC(═NR5f)NR5fR5f, (CH2)rS(O)2NR5fR5f, (CH2)rNR5fS(O)2R5b, and (CH2)rphenyl substituted with 0–3 R5e;
- R5d, at each occurrence, is selected from methyl, CF3, C2-6 alkyl substituted with 0–2 R5e, C3-8 alkenyl substituted with 0–2 R5e, C3-8 alkynyl substituted with 0–2 R5e, and a C3-10 carbocyclic residue substituted with 0–3 R5e;
- R5e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, SH, (CH2)rSC1-5 alkyl, (CH2)rNR5fR5f, and (CH2)rphenyl;
- R5f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
- R5g is independently selected from —C(O)R5b, —C(O)OR5d, —C(O)NR5fR5f, —CN, and (CH2)rphenyl;
- R, at each occurrence, is selected from H, C1-6 alkyl substituted with R5e, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, and (CH2)rphenyl substituted with R5e;
- R6, at each occurrence, is selected from C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, NO2, CN, (CR′R′)rNR6aR6a, (CR′R′)rOH, (CR′R′)rO(CR′R′)rR6d, (CR′R′)rSH, (CR′R′)rC(O)H, (CR′R′)rS(CR′R′)rR6d, (CR′R′)rSC(O)(CR′R′)rR6b, (CR′R′)rC(O)OH, (CR′R′)rC(O)(CR′R′)rR6b, (CR′R′)rNR6aR6a, (CR′R′)rC(O)NR6aR6a, (CR′R′)rNR6fC(O)(CR′R′)rR6b, (CR′R′)rC(O)O(CR′R′)rR6d, (CR′R′)rOC(O)(CR′R′)rR6b, (CR′R′)rOC(O)NR6a(CR′R′)rR6d, (CR′R′)rNR6aC(O)NR6a(CR′R′)rR6d, (CR′R′)rNR6aC(S)NR6a(CR′R′)rR6d, (CR′R′)rNR6fC(O)O(CR′R′)rR6b, (CR′R′)rC(═NR6f)NR6aR6a, (CR′R′)rNHC(═NR6f)NR6fR6f, (CR′R′)rS(O)p(CR′R′)rR6b, (CR′R′)rS(O)2NR6aR6a, (CR′R′)rNR6fS(O)2NR6aR6a, (CR′R′)rNR6fS(O)2(CR′R′)rR6b, C1-6 haloalkyl, C2-8 alkenyl substituted with 0–3 R′, C2-8 alkynyl substituted with 0–3 R′, (CR′R′)rphenyl substituted with 0–3 R6e, and a (CH2)r-5–6 membered heterocyclic system containing 1–2 heteroatoms selected from N, O, and S, substituted with 0–2 R6e;
- alternatively, two R6 on adjacent atoms on R1 may join to form a cyclic acetal;
- R6a, at each occurrence, is selected from H, methyl substituted with 0–1 R6g, C2-6 alkyl substituted with 0–2 R6e, C3-8 alkenyl substituted with 0–2 R6e, C3-8 alkynyl substituted with 0–2 R6e, a (CH2)r—C3-10 carbocyclic residue substituted with 0–5 R6e, and a (CH2)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–2 R6e;
- R6b, at each occurrence, is selected from H, C1-6 alkyl substituted with 0–2 R6e, C3-8 alkenyl substituted with 0–2 R6e, C3-8 alkynyl substituted with 0–2 R6e, a (CH2)rC3-6 carbocyclic residue substituted with 0–3 R6e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–2 R6e;
- R6d, at each occurrence, is selected from C3-8 alkenyl substituted with 0–2 R6e, C3-8 alkynyl substituted with 0–2 R6e, methyl, CF3, C2-6 alkyl substituted with 0–3 R6e, C2-4 haloalkyl, a (CH2)r—C3-10 carbocyclic residue substituted with 0–3 R6e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R6e;
- R6e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, SH, (CH2)rSC1-5 alkyl, (CH2)rNR6fR6f, and (CH2)rphenyl;
- R6f, at each occurrence, is selected from H, C1–5 alkyl, and C3–6 cycloalkyl, and phenyl;
- R6g is independently selected from —C(O)R6b, —C(O)OR6d, —C(O)NR6fR6f, and (CH2)rphenyl;
- R7, at each occurrence, is selected from C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, Br, I, F, NO2, CN, (CR′R′)rNR7aR7a, (CR′R′)rOH, (CR′R′)rO(CR′R′)rR7d, (CR′R′)rSH, (CR′R′)rC(O)H, (CR′R′)rS(CR′R′)rR7d, (CR′R′)rC(O)OH, (CR′R′)rC(O)(CR′R′)rR7b, (CR′R′)rC(O)NR7aR7a, (CR′R′)rNR7fC(O)(CR′R′)rR7b, (CR′R′)rC(O)O(CR′R′)rR7d, (CR′R′)rOC(O)(CR′R′)rR7b, (CR′R′)rOC(O)NR7a(CR′R′)rR7a, (CR′R′)rNR7aC(O)NR7a(CR′R′)rR7a, (CR′R′)rNR7fC(O)O(CR′R′)rR7d, (CR′R′)rC(═NR7f)NR7aR7a, (CR′R′)rNHC(═NR7f)NR7fR7f, (CR′R′)rS(O)p(CR′R′)rR7b, (CR′R′)rS(O)2NR7aR7a, (CR′R′)rNR7aS(O)2NR7aR7a, (CR′R′)rNR7fS(O)2(CR′R′)rR7b, C1–6 haloalkyl, C2-8 alkenyl substituted with 0–3 R′, C2-8 alkynyl substituted with 0–3 R′, (CR′R′)r C3-10 carbocyclic residue and (CR′R′)rphenyl substituted with 0–3 R7e;
- alternatively, two R7 on adjacent atoms on R2 may join to form a cyclic acetal;
- R7a, at each occurrence, is independently selected from H, methyl substituted with 0–1 R7g, C2-6 alkyl substituted with 0–2 R7e, C3-8 alkenyl substituted with 0–2 R7e, C3-8 alkynyl substituted with 0–2 R7e, a (CH2)r—C3-10 carbocyclic residue substituted with 0–5 R7e, and a (CH2)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–2 R7e;
- R7b, at each occurrence, is selected from C1-6 alkyl substituted with 0–2 R7e, C3-8 alkenyl substituted with 0–2 R7e, C3-8 alkynyl substituted with 0–2 R7e, a (CH2)rC3-6 carbocyclic residue substituted with 0–3 R7e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–2 R7e;
- R7d, at each occurrence, is selected from C3-8 alkenyl substituted with 0–2 R7e, C3-8 alkynyl substituted with 0–2 R7e, methyl, CF3, C2-4 haloalkyl, C2-6 alkyl substituted with 0–3 R7e, a (CH2)rC3-10 carbocyclic residue substituted with 0–3 R7e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R7e;
- R7e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, SH, C(O)OC1-5 alkyl, (CH2)rSC1-5 alkyl, (CH2)rNR7fR7f, and (CH2)rphenyl;
- R7f, at each occurrence, is selected from H, C1-5 alkyl, and C3-6 cycloalkyl, and phenyl;
- R7g is independently selected from —C(O)R7b, —C(O)OR7d, —C(O)NR7fR7f, and (CH2)rphenyl;
- R′, at each occurrence, is selected from H, C1-6 alkyl substituted with R6e, C2-8 alkenyl, C2-8 alkynyl, (CH2)rC3-6 cycloalkyl, and (CH2)rphenyl substituted with R6e;
- R9 is selected from H, C1-4 alkyl, C3-4 cycloalkyl, —C(O)H, and —C(O)—C1-4alkyl;
- R10 is independently selected from H, and C1-4alkyl substituted with 0–1 R10b, alternatively, two R10 form ═O;
- R10b, at each occurrence, is independently selected from —OH, —SH, —NR10cR10c, —C(O)NR10cR10C, and —NHC(O)R10c;
- R10c is selected from H, C1-4 alkyl and C3-6 cycloalkyl;
- R11 is selected from H, C1-4 alkyl, (CHR)qOH, (CHR)qSH, (CHR)qOR11d, (CHR)qS(O)pR11d, (CHR)rC(O)R11b, (CHR)rNR11aR11a, (CHR)rC(O)NR11aR11a, (CHR)rC(O)R11aOR11d, (CHR)qNR11aC(O)R11b, (CHR)qNR11aC(O)OR11d, (CHR)qOC(O)NR11aR11a, (CHR)rC(O)OR11d, a (CHR)r—C3-6 carbocyclic residue substituted with 0–5 R11e, and a (CHR)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R11e;
- R11a, at each occurrence, is independently selected from H, C1-4 alkyl, C3-4 alkenyl, C3-4 alkynyl, (CH2)rC3-6 cycloalkyl, a (CH2)rC3-6 carbocyclic residue substituted with 0–5 R11e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R11e;
- R11b, at each occurrence, is independently selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a (CH2)r—C3-6 carbocyclic residue substituted with 0–2 R11e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R11e;
- R11d, at each occurrence, is independently selected from H, methyl, —CF3, C2-4 alkyl, C3-6 alkenyl, C3-6 alkynyl, a C3-6 carbocyclic residue substituted with 0–3 R11e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R11e;
- R11e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, —O—C1-6 alkyl, SH, (CH2)rSC1-5 alkyl, (CH2)rNR11fR11f, and (CH2)rphenyl;
- R11f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
- R12 is selected from H, C1-4 alkyl, (CHR)qOH, (CHR)qSH, (CHR)qOR12d, (CHR)qS(O)pR12d, (CHR)rC(O)R12b, (CHR)rNR12aR12a, (CHR)rC(O)NR12aR12a, (CHR)rC(O)NR12aOR12d, (CHR)qNR12aC(O)R12b, (CHR)qNR12aC(O)OR12d, (CHR)qOC(O)NR12aR12a, (CHR)rC(O)OR12d, a (CHR)r—C3-6 carbocyclic residue substituted with 0–5 R12e, and a (CHR)r-5–10 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R12e;
- R12a, at each occurrence, is independently selected from H, C1-4 alkyl, C3-4 alkenyl, C3-4 alkynyl, (CH2)rC3-6 cycloalkyl, a (CH2)r—C3-6 carbocyclic residue substituted with 0–5 R12e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R12e;
- R12b, at each occurrence, is independently selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a (CH2)rC3-6 carbocyclic residue substituted with 0–2 R12e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R12e;
- R12d, at each occurrence, is independently selected from H, methyl, —CF3, C2-4 alkyl, C3-6 alkenyl, C3-6 alkynyl, a C3-6 carbocyclic residue substituted with 0–3 R12e, and a (CH2)r-5–6 membered heterocyclic system containing 1–4 heteroatoms selected from N, O, and S, substituted with 0–3 R12e;
- R12e, at each occurrence, is selected from C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-6 cycloalkyl, Cl, F, Br, I, CN, NO2, (CF2)rCF3, (CH2)rOC1-5 alkyl, OH, —O—C1-6 alkyl, SH, (CH2)rSC1-5 alkyl, (CH2)rNR12fR12f, and (CH2)rphenyl;
- R12f, at each occurrence, is selected from H, C1-6 alkyl, and C3-6 cycloalkyl;
- R13, at each occurrence, is independently selected from H, and C1-4alkyl substituted with 0–1 R13b, —OH, —NH2, F, Cl, Br, I, —OR13a, —N(R13a)2, and C1-4 alkyl substituted with 0–3 R13b;
- R13a is selected from H, C1-4 alkyl and C3-6 cycloalkyl;
- R13b, at each occurrence, is independently selected from —OH, —SH, —NR13cR13c, —C(O)NR13cR13c, and —NHC(O)R13c;
- R13c is selected from H, C1-4 alkyl and C3-6 cycloalkyl;
- l is selected from 1, 2 and 3;
- n is 1;
- m is selected from 0 and 1;
- p, at each occurrence, is independently selected from 0, 1, and 2;
- q, at each occurrence, is independently selected from 1, 2, 3, and 4;
- r, at each occurrence, is independently selected from 0, 1, 2, 3, and 4;
- t, at each occurrence, is independently selected from 2, 3, and 4;
- s is selected from 0 and 1.
61 more elements
Dependencies are inferred from the claim text.